7-Bromo-5-methoxy-3,4-dihydronaphthalen-1(2H)-one

Catalog No.: 
ACBLVZ812
CAS No.: 
1336953-53-7
Molecular Formula: 
C11H11BrO2
Molecular Weight: 
255.11
7-Bromo-5-methoxy-3,4-dihydronaphthalen-1(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$239.00InquiryInquiry
250mg95%$359.00InquiryInquiry
1g95%$895.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-5-methoxy-3,4-dihydronaphthalen-1(2H)-one
IUPAC Name7-bromo-5-methoxy-3,4-dihydronaphthalen-1(2H)-one
Molecular FormulaC11H11BrO2
Molecular Weight255.11
SMILESCOC1=C2CCCC(=O)C2=CC(Br)=C1
InChI KeyMVAWJSZLKXGWKX-UHFFFAOYSA-N
Synonym7-BROMO-5-METHOXY-1,2,3,4-TETRAHYDRONAPHTHALEN-1-ONE;7-bromo-5-methoxy-3,4-dihydronaphthalen-1(2H)-one;1(2H)-Naphthalenone, 7-bromo-3,4-dihydro-5-methoxy-
CAS No.1336953-53-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBLVZ812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBLVZ812 route product structure diagram
    ACBLVZ8121336953-53-7
Inquiry

2. ACBLVZ812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBLVZ812 route product structure diagram
    ACBLVZ8121336953-53-7
Inquiry

3. ACBLVZ812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBLVZ812 route product structure diagram
    ACBLVZ8121336953-53-7
Inquiry

Comments (0)